Lukes A

No ORCID on file · 2 papers in corpus · active 2020-2023
2023
Clinical pharmacokinetics ·doi:10.1007/s40262-023-01269-9

Background and objectiveRelugolix is a gonadotropin-releasing hormone receptor antagonist. Relugolix 40-mg monotherapy is associated with vasomotor symptoms and long-term bone mineral density loss due to hypoestrogenism. This study assessed…

2020
Journal of Gynecologic Surgery ·doi:10.1089/gyn.2020.0021

Objective: This article reports on 3-year clinical outcomes of the Sonography Guided Transcervical Ablation of Uterine Fibroids (SONATA) pivotal trial of transcervical fibroid ablation (TFA) in women with symptomatic uterine myomata. Materi…